Product Images Ceftriaxone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Ceftriaxone NDC 0143-9859 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural formula - ceftriaxone for injection 1

Structural formula - ceftriaxone for injection 1

NDC 0143-9859-01 Rx only CEFTRIAXONE FOR INJECTION, USP 250 mg/Vial EQUIVALENT TO 250 MG CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT A 350 mg/mL concentration is not recom- mended for the 250 mg vial since it may not be possible to withdraw the entire contents. For IV or IM administration and USUAL DOSAGE: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. Storage After Reconstitution: See package insert. - ceftriaxone for injection 2

NDC 0143-9859-01 Rx only CEFTRIAXONE FOR INJECTION, USP 250 mg/Vial EQUIVALENT TO 250 MG CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT A 350 mg/mL concentration is not recom- mended for the 250 mg vial since it may not be possible to withdraw the entire contents. For IV or IM administration and USUAL DOSAGE: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. Storage After Reconstitution: See package insert. - ceftriaxone for injection 2

This is a description of a medication called Ceftriaxone for injection. The NDC number is 0143385801 and it has a concentration of 350mg/ml. It is not recommended to use the 250mg vial as it may not be possible to withdraw the entire contents. The medication can be administered through IV or IM, and the usual dosage should be referenced in the package insert. The equivalent dosage to 250mg of Ceftriaxone is mentioned. Prior to reconstitution, the medication should be stored at 20-25°C and protected from light. The medication is distributed by West-Ward in the US and manufactured by Hikma Farmaceutica in Portugal. The NDC number is 0143-9859.01.*

NDC 0143-9858-01 Rx only CEFTRIAXONE FOR INJECTION, USP 500 mg/Vial EQUIVALENT TO 500 MG CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 1 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 4.8 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solution contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. ​​​​​​​​Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 3

NDC 0143-9858-01 Rx only CEFTRIAXONE FOR INJECTION, USP 500 mg/Vial EQUIVALENT TO 500 MG CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 1 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 4.8 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solution contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. ​​​​​​​​Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 3

This is a description of a drug called Ceftriaxone. It is available in a single-dose vial and has an NDC code of 0143-9858-01. It is used for intravenous or intramuscular administration and is manufactured by Hikma Farmaceutica (Portugal), SA. The drug should be stored at a temperature of 20°C to 25°C prior to reconstitution. The dosage and storage instructions can be found in the package insert.*

NDC 0143-9857-01 Rx only CEFTRIAXONE FOR INJECTION, USP 1 gram/Vial EQUIVALENT TO 1 GRAM CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 2.1 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 9.6 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solution contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 4

NDC 0143-9857-01 Rx only CEFTRIAXONE FOR INJECTION, USP 1 gram/Vial EQUIVALENT TO 1 GRAM CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 2.1 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 9.6 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solution contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 4

This text provides instructions for administering CEFTRIAXONE, an antibiotic drug, either through intramuscular or intravenous routes. The recommended amounts of diluents and their equivalents in terms of the drug are also stated. The dosage and storage information after reconstitution are available in the package insert. The drug is to be stored at a controlled room temperature and protected from light. The text also includes the manufacturers and the distributor's information.*

NDC 0143-9856-01 Rx only CEFTRIAXONE FOR INJECTION, USP 2 grams/Vial EQUIVALENT TO 2 GRAMS CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 4.2 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 19.2 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solutin contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 5

NDC 0143-9856-01 Rx only CEFTRIAXONE FOR INJECTION, USP 2 grams/Vial EQUIVALENT TO 2 GRAMS CEFTRIAXONE FOR IV OR IM USE Single Dose Vial PROTECT FROM LIGHT For IM administration: Reconstitute with 4.2 mL 1% Lidocaine Hydrochloride Injection, USP or Sterile Water for Injection, USP. Each 1 mL of solution con- tains approximately 350 mg equivalent of ceftriaxone. For IV administration: Reconstitute with 19.2 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of solutin contains approximately 100 mg equivalent of ceftriaxone. Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent. USUAL DOSAGE and Storage After Reconstitution: See package insert. Storage Prior to Reconstitution: Store powder at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. - ceftriaxone for injection 5

This is a drug label for Ceftriaxone, an antibiotic used for both Intravenous and Intramuscular injections in humans. The label provides information about the packaging, reconstitution, administration, and dosage of the drug. The content is produced by Hikma Farmaceutica in Portugal and is distributed by West-Ward in Eatontown, USA. Storage guidelines are also provided.*

ceftriaxone for injection 6

ceftriaxone for injection 6

This text contains product information such as GTIN, SN, and EXP and LOT codes.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.